Q&A: John Ioannidis Talks Transparency in Biomedical Literature
Q&A: John Ioannidis Talks Transparency in Biomedical Literature
The Stanford University researcher discusses a new study on measures such as data sharing and funding disclosures.
Q&A: John Ioannidis Talks Transparency in Biomedical Literature
Q&A: John Ioannidis Talks Transparency in Biomedical Literature

The Stanford University researcher discusses a new study on measures such as data sharing and funding disclosures.

The Stanford University researcher discusses a new study on measures such as data sharing and funding disclosures.

transparency
EPA Postpones Decision on Rule to Restrict Scientific Input
EPA Postpones Decision on Rule to Restrict Scientific Input
Jef Akst | Oct 19, 2018
It will be more than a year before the agency institutes or rejects the controversial changes proposed by former EPA head Scott Pruitt.
Studies Unable to Reproduce Results of Two Diabetes Papers
Studies Unable to Reproduce Results of Two Diabetes Papers
Anna Azvolinsky | Aug 10, 2018
The original work found that an anti-malaria drug or the neurotransmitter GABA could increase the number of insulin-producing pancreatic cells in mice.
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Effort to Reproduce Cancer Studies Scales Down to 18 Papers
Diana Kwon | Aug 1, 2018
The Reproducibility Project: Cancer Biology initially aimed to replicate the results of 50 high-impact research articles.
US Scientists’ Letter Calls for Transparency in Animal Research
US Scientists’ Letter Calls for Transparency in Animal Research
Ashley Yeager | Jun 21, 2018
Nearly 600 signatories, including four Nobel Prize winners, urge openness about animal experiments.
Medical Statistician Doug Altman Dies
Medical Statistician Doug Altman Dies
Kerry Grens | Jun 5, 2018
The cofounder of the EQUATOR Network devoted his career to boosting transparency and improving the quality of clinical research.
EPA Seeks to Restrict the Science Used in Policymaking
EPA Seeks to Restrict the Science Used in Policymaking
Kerry Grens | Apr 23, 2018
Republican politicians have been trying to limit data to only those publicly available, but opponents say that would neglect private, yet important, information.
Investigation Questions Transparency for Failed TB Vax
Investigation Questions Transparency for Failed TB Vax
Jef Akst | Jan 11, 2018
The BMJ inquiry finds that researchers presented only select results from animal experiments when applying for funding and approval for human trials.
Scientists Continue to Use Outdated Methods
Scientists Continue to Use Outdated Methods
Catherine Offord | Jan 9, 2018
The use of underperforming computational tools is a major offender in science’s reproducibility crisis—and there’s growing momentum to avoid it.
Clinical Trial Reporting for Pharma-Sponsored Trials Shows Improvement
Clinical Trial Reporting for Pharma-Sponsored Trials Shows Improvement
Diana Kwon | Dec 4, 2017
The Good Pharma Scorecard finds some big pharmaceutical companies are meeting legal standards for disclosing results—but many studies still go unreported.